Ascites, refractory ascites and hyponatremia in cirrhosis
Authors:
Open Access
- 24 April 2017
- journal article
- research article
- Published by Oxford University Press (OUP) in Gastroenterology Report
- Vol. 5 (2) , 104-112
Abstract
Ascites is the most common complication related to cirrhosis and is associated with increased morbidity and mortality. Ascites is a consequence of the loss of compensatory mechanisms to maintain the overall effective arterial blood volume due to worsening splanchnic arterial vasodilation as a result of clinically significant portal hypertension. In order to maintain effective arterial blood volume, vasoconstrictor and antinatriuretic pathways are activated, which increase overall sodium and fluid retention. As a result of progressive splanchnic arterial vasodilation, intestinal capillary pressure increases and results in the formation of protein-poor fluid within the abdominal cavity due to increased capillary permeability from the hepatic sinusoidal hypertension. In some patients, the fluid can translocate across diaphragmatic fenestrations into the pleural space, leading to hepatic hydrothorax. In addition, infectious complications such as spontaneous bacterial peritonitis can occur. Eventually, as the liver disease progresses related to higher portal pressures, loss of a compensatory cardiac output and further splanchnic vasodilation, kidney function becomes compromised from worsening renal vasoconstriction as well as the development of impaired solute-free water excretion and severe sodium retention. These mechanisms then translate into significant clinical complications, such as refractory ascites, hepatorenal syndrome and hyponatremia, and all are linked to increased short-term mortality. Currently, liver transplantation is the only curative option for this spectrum of clinical manifestations but ongoing research has led to further insight on alternative approaches. This review will further explore the current understanding on the pathophysiology and management of ascites as well as expand on two advanced clinical consequences of advanced liver disease, refractory ascites and hyponatremia.Keywords
This publication has 86 references indexed in Scilit:
- Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney DiseaseNew England Journal of Medicine, 2012
- Factors related to quality of life in patients with cirrhosis and ascites: Relevance of serum sodium concentration and leg edemaJournal of Hepatology, 2012
- Hospital Readmissions Among Patients With Decompensated CirrhosisAmerican Journal of Gastroenterology, 2012
- Endothelial dysfunction in the regulation of cirrhosis and portal hypertensionLiver International, 2011
- Impact of pretransplant hyponatremia on outcome following liver transplantation #Hepatology, 2009
- MELD score and serum sodium in the prediction of survival of patients with cirrhosis awaiting liver transplantationGut, 2007
- Restricted use of albumin for spontaneous bacterial peritonitisGut, 2007
- Peritoneovenous Shunting as Compared with Medical Treatment in Patients with Alcoholic Cirrhosis and Massive AscitesNew England Journal of Medicine, 1989
- Pathogenesis of Sodium and Water Retention in High-Output and Low-Output Cardiac Failure, Nephrotic Syndrome, Cirrhosis, and PregnancyNew England Journal of Medicine, 1988
- Prognostic value of spontaneous hyponatremia in cirrhosis with ascitesDigestive Diseases and Sciences, 1976